Showing results (201-210 of 221) with videos related to
Sort By:
Pageof 23
Scientific Reports|July 14, 2018
Author Correction: Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpoxB Ogunjimi, J Van den Bergh, P Meysman, et al.The British Journal of Dermatology|July 22, 2014
Health-related quality of life in patients with melanoma expressed as utilities and disability weightsI Tromme, B Devleesschauwer, P Beutels, et al.Orphanet Journal of Rare Diseases|April 7, 2020
Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measuresP Vanherpe, S Fieuws, A D'Hondt, et al.Neurology|September 30, 2010
Mutations in SACS cause atypical and late-onset forms of ARSACSJ Baets, T Deconinck, K Smets, et al.Vaccine|October 2, 2007
Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP-IPV-PRP approximately T-HBs) combination vaccineS Stojanov, J G Liese, B H Belohradsky, et al.Leukemia Research|April 26, 2016
Medical costs of treatment and survival of patients with acute myeloid leukemia in BelgiumA L Van de Velde, P Beutels, E L Smits, et al.Sexually Transmitted Infections|June 1, 2004
The seroepidemiology of herpes simplex virus type 1 and 2 in EuropeR G Pebody, N Andrews, D Brown, et al.Journal of Viral Hepatitis|March 27, 2007
The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virusG Kafatos, C Anastassopoulou, A Nardone, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 4, 2014
Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotavirusesJ Matthijnssens, M Zeller, E Heylen, et al.Neurology|May 26, 2010
Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouseI Taes, A Goris, R Lemmens, et al.Pageof 23